Nelly Mugo, MBChB, MMed, MPH

Research Associate Professor, Global Health

Prof. Nelly R. Mugo is an associate research professor in the Department of Global Health at the University of Washington, a senior principal clinical research scientist at the Kenya Medical Research Institute (KEMRI), and a reproductive health specialist with three decades of work experience. Her research focus has been on the prevention of HIV and cervical cancer among other reproductive health research work.  She has been an investigator on two landmark clinical trials, the Partners PrEP study that contributed evidence to inform the change of indication for use of Truvada as HIV prevention pre-exposure prophylaxis (PrEP) and a protocol lead for the ongoing ‘Kenya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study –’ that has provided evidence on the efficacy of single-dose HPV vaccination. She is a member of the International Papillomavirus Society education committee, and the Kenya Obstetrics and Genecology society and has contributed to several World Health Organization and Kenya ministry of health working group scientific committees. She is widely published in peer review journals.

Publications

  1. Harrington, EK, Ouma, DC, Pike, M, Awuor, M, Kimanthi, S, Onono, M et al.. Exploring Adolescents' Contraceptive Preferences and Trade-Offs: Findings From a Discrete Choice Experiment in Kenya. Stud Fam Plann. 2025; :. doi: 10.1111/sifp.12280. PubMed PMID:39780241 .
  2. Ogello, V, Mwangi, P, Kwena, Z, Thuo, N, Makokha, C, Owidi, E et al.. Preferences for and acceptability of long-acting HIV prevention products among pregnant and lactating women accessing health services in Kenya: a mixed method cross-sectional analysis. BMC Infect Dis. 2025;25 (1):37. doi: 10.1186/s12879-024-10414-z. PubMed PMID:39773105 PubMed Central PMC11705746.
  3. Okello, P, Velloza, J, Ogello, V, Owidi, E, Mogere, P, Gakuo, S et al.. Acceptability and feasibility of a urine-based tenofovir adherence assay for monitoring and providing feedback on PrEP adherence in Kenya. AIDS Care. 2025;37 (2):324-336. doi: 10.1080/09540121.2024.2444556. PubMed PMID:39733245 .
  4. Omole, TE, Nguyen, HM, Marcinow, A, Oo, MM, Jahan, N, Ssemaganda, A et al.. Pre-HIV α4β7hi CD4+ T cells and HIV risk among heterosexual individuals in Africa. J Infect Dis. 2024; :. doi: 10.1093/infdis/jiae638. PubMed PMID:39720913 .
  5. Casmir, E, Wairimu, N, Etyang, L, Mogaka, F, Oware, K, Nyerere, B et al.. Expanding the reach of HIV pre-exposure prophylaxis (PrEP) among Kenyan adolescent girls and young women: the acceptability of HIV PrEP integration into post-abortal care services. AIDS Care. 2025;37 (2):233-243. doi: 10.1080/09540121.2024.2443678. PubMed PMID:39700128 .
Search PubMed

Comments are closed.